Chapla Agarwal

Chapla Agarwal

Auto-generated profile, based on publicly available information

Chapla Agarwal

Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, Colorado

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 June 2009 in Pharmaceutical Research
Verified
Journal Article
Closed access
PDF file
MKManjinder Kaur
Manjinder Kaur
BVBalaiya Velmurugan
Balaiya Velmurugan
SRSubapriya Rajamanickam
Subapriya Rajamanickam
RARajesh Agarwal
Rajesh Agarwal
CAChapla Agarwal
Chapla Agarwal

14 January 2020 in Molecular Carcinogenesis
Verified
Journal Article
Closed access
PDF file
Gagan DeepGagan Deep
Gagan Deep
AJAnil Jain
Anil Jain
AKAshish Kumar
Ashish Kumar
CAChapla Agarwal
Chapla Agarwal
SKSusy Kim
Susy Kim
RARajesh Agarwal
Rajesh Agarwal

1 January 2014 in Molecular Cancer
Verified
Journal Article
Open access
PDF file
GDGagan Deep
Gagan Deep
AJAnil K Jain
Anil K Jain
ARAnand Ramteke
Anand Ramteke
HTHarold Ting
Harold Ting
KVKavitha C Vijendra
Kavitha C Vijendra
RARajesh Agarwal
Rajesh Agarwal
A better molecular understanding of prostate carcinogenesis is warranted to devise novel targeted preventive and therapeutic strategies against prostate cancer (PCA), a major cause of mortality among men. Here, we examined the role of two epithelial-to-mesenchymal transition (EMT) regulators, the adherens junction protein E-cadherin and its transcriptional repressor SNAI1, in regulating the aggressiveness of PCA cells. The growth rate of human prostate carcinoma PC3 cells with stable knock-down of E-cadherin (ShEC-PC3) and respective control cells (Sh-PC3) was compared in MTT and clonogenic assays in cell culture and in nude mouse xenograft model in vivo. Stemness of ShEC-PC3 and Sh-PC3 cells was analyzed in prostasphere assay. Western blotting and immunohistochemistry (IHC) were used to study protein expression changes following E-cadherin and SNAI1 knock-down. Small interfering RNA (siRNA) technique was employed to knock- down SNAI1 protein expression in ShEC-PC3 cells. ShEC-PC3 cells exerted higher proliferation rate both in cell culture and in athymic nude mice compared to Sh-PC3 cells. ShEC-PC3 cells also formed larger and a significantly higher number of prostaspheres suggesting an increase in the stem cell-like population with E-cadherin knock-down. Also, ShEC-PC3 prostaspheres disintegration, in the presence of serum and attachment, generated a bigger mass of proliferating cells as compared to Sh-PC3 prostaspheres. Immunoblotting/IHC analyses showed that E-cadherin knock-down increases the expression of regulators/biomarkers for stemness (CD44, cleaved Notch1 and Egr-1) and EMT (Vimentin, pSrc-tyr416, Integrin β3, β-catenin, and NF-κB) in cell culture and xenograft tissues. The expression of several bone metastasis related molecules namely CXCR4, uPA, RANKL and RunX2 was also increased in ShEC-PC3 cells. Importantly, we observed a remarkable increase in SNAI1 expression in cytoplasmic and nuclear fractions, prostaspheres and xenograft tissues of ShEC-PC3 cells. Furthermore, SNAI1 knock-down by specific siRNA strongly inhibited the prostasphere formation, clonogenicity and invasiveness, and decreased the level of pSrc-tyr416, total Src and CD44 in ShEC-PC3 cells. Characterization of RWPE-1, WPE1-NA22, WPE1-NB14 and DU-145 cells further confirmed that low E-cadherin is associated with higher SNAI1 expression and prostasphere formation. Together, these results suggest that E-cadherin loss promotes SNAI1 expression that controls the aggressiveness of PCA cells.

16 June 2010 in Molecular Carcinogenesis
Verified
Journal Article
Closed access
PDF file
BVBalaiya Velmurugan
Balaiya Velmurugan
RSRana Pratap Singh
Rana Pratap Singh
RARajesh Agarwal
Rajesh Agarwal
CAChapla Agarwal
Chapla Agarwal

1 October 2012 in Toxicology and Applied Pharmacology
Verified
Journal Article
Closed access
NTNeera Tewari-Singh
Neera Tewari-Singh
AJAnil K. Jain
Anil K. Jain
SISwetha Inturi
Swetha Inturi
DADavid A. Ammar
David A. Ammar
CAChapla Agarwal
Chapla Agarwal
RARajesh Agarwal
Rajesh Agarwal

19 January 2012 in Carcinogenesis
Verified
Journal Article
Open access
PDF file
SSSangeeta Shrotriya
Sangeeta Shrotriya
GDGagan Deep
Gagan Deep
MGMallikarjuna Gu
Mallikarjuna Gu
MKManjinder Kaur
Manjinder Kaur
AJAnil K. Jain
Anil K. Jain
CAChapla Agarwal
Chapla Agarwal
Head and neck squamous cell carcinoma (HNSCC) accounts for 6% of all malignancies in USA and unfortunately the recurrence of secondary primary tumors and resistance against conventional treatments decrease the overall 5 year survival rate in HNSCC patients. Thus, additional approaches are needed to control HNSCC. Here, for the first time, employing human HNSCC Detroit 562 and FaDu cells as well as normal human epidermal keratinocytes, we investigate grape seed extract (GSE) efficacy and associated mechanism in both cell culture and nude mice xenografts. GSE selectively inhibited the growth and caused cell cycle arrest and apoptotic death in both Detroit 562 and FaDu cells by activating DNA damage checkpoint cascade, including ataxia telangiectasia mutated/ataxia telangiectasia-Rad3-related–checkpoint kinase 1/2–cell division cycle 25C as well as caspases 8, 9 and 3. Consistent with these results, GSE treatment resulted in a strong DNA damage and a decrease in the levels of DNA repair molecules breast cancer gene 1 and Rad51 and DNA repair foci. GSE-caused accumulation of intracellular reactive oxygen species was identified as a major mechanism of its effect for growth inhibition, DNA damage and apoptosis, which was remarkably reversed by antioxidant N -acetylcysteine. GSE feeding to nude mice decreased Detroit 562 and FaDu xenograft tumor growth by 67 and 65% ( P < 0.001), respectively. In immunohistochemical analysis, xenografts from GSE-fed groups showed decreased proliferation but increased DNA damage and apoptosis. Together, these findings show that GSE targets both DNA damage and repair and provide mechanistic insights for its efficacy selectively against HNSCC both in cell culture and mouse xenograft, supporting its translational potential against HNSCC.